OIG
Report: Unit
of Measure Inconsistencies in the
Medicaid Prescription Drug Program
(OEI-05-07-00050; 11/07)
Review
of 340B Prices (OEI-05-02-00073;
07/06) - This report reviews 340B
prices charged to a subset of covered
entites and compares them to the 340B
ceiling prices.
"Deficiencies
in the Oversight of the 340B Drug
Pricing Program" (OEI-05-02-00072)
October 2005
"Appropriateness
of 340B Drug Prices," (OEI-05-02-00070)
June 2004 - On October 21, the
Office of Inspector General withdrew
report OEI-05-02-00070 entitled "Appropriateness
of 340B Drug Prices," dated June 2004.
The OIG withdrew the report because
of problems with the underlying data
used in developing the report's findings.
The OIG has issued a memorandum to
the Administrators of the Centers
for Medicare & Medicaid Services
and Health Resources and Services
Administration announcing the withdrawal
of the report and OIG plans for additional
work related to the 340B program.
